Index Performance
+4.03%
MDBH
+2.90%
SPY
-1.16%
DIA
Overview
Description
Biotech companies between $30 million and $400 million market capitalization
- TickerMDBH
- Inception Date12/07/2023
- WeightingEqual
- # of holdings115
What's inside?
Holdings
All holdings as of April 30, 2024
CSV download
| Eliem Therapeutics, Inc. (ELYM) | 2.47% | $196.56M | N/A | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI) | 1.81% | $167.78M | N/A | N/A | N/A |
| Stoke Therapeutics, Inc. (STOK) | 1.62% | $574.86M | -29.22% | 46.14% | 4.20 |
| Galectin Therapeutics, Inc. (GALT) | 1.60% | $217.28M | N/A | N/A | N/A |
| Curis, Inc. (CRIS) | 1.40% | $90.47M | -1.37% | 95.34% | 5.64 |
| ProKidney Corp. (DNAC) | 1.38% | $127.25M | N/A | N/A | N/A |
| Aldeyra Therapeutics, Inc. (ALDX) | 1.32% | $234.09M | N/A | N/A | N/A |
| Leap Therapeutics, Inc. (LPTX) | 1.32% | $79.37M | N/A | N/A | N/A |
| CorMedix, Inc. (CRMD) | 1.30% | $288.93M | -100.00% | N/A | N/A |
| Design Therapeutics, Inc. (DSGN) | 1.28% | $198.86M | N/A | N/A | N/A |
| Nuvation Bio, Inc. (NUVB) | 1.23% | $651.96M | N/A | N/A | N/A |
| XBiotech, Inc. (XBIT) | 1.22% | $233.56M | -100.00% | N/A | N/A |
| Seres Therapeutics, Inc. (MCRB) | 1.19% | $149.59M | 1,672.24% | 88.04% | 2.10 |
| HOOKIPA Pharma, Inc. (HOOK) | 1.16% | $85.67M | 41.27% | 82.35% | -1.69 |
| Avid Bioservices, Inc. (CDMO) | 1.14% | $484.35M | -11.06% | 7.05% | 4.31 |
| Humacyte, Inc. (HUMA) | 1.14% | $466.81M | N/A | N/A | N/A |
| X4 Pharmaceuticals, Inc. (XFOR) | 1.13% | $188.09M | N/A | N/A | N/A |
| Shattuck Labs, Inc. (STTK) | 1.13% | $498.33M | 154.14% | -143.93% | 107.01 |
| VistaGen Therapeutics, Inc. (VTGN) | 1.12% | $130.53M | 129.06% | 65.19% | 25.66 |
| Affimed NV (AFMD) | 1.10% | $81.47M | -79.42% | N/A | -5.46 |
| Black Diamond Therapeutics, Inc. (BDTX) | 1.09% | $292.59M | N/A | N/A | N/A |
| 23andMe Holding Co. (ME) | 1.06% | $158.41M | -33.15% | 28.20% | 1.11 |
| Agenus, Inc. (AGEN) | 1.06% | $245.85M | 59.47% | 89.32% | 3.73 |
| MiNK Therapeutics, Inc. (INKT) | 1.04% | $34.35M | N/A | N/A | N/A |
| TScan Therapeutics, Inc. (TCRX) | 1.02% | $355.90M | 55.52% | 74.53% | 13.44 |
| Co-Diagnostics, Inc. (CODX) | 1.02% | $36.26M | -97.10% | -446.20% | -16.67 |
| INmune Bio, Inc. (INMB) | 1.01% | $233.97M | -58.56% | N/A | 1,142.28 |
| Taysha Gene Therapies, Inc. (TSHA) | 0.99% | $454.45M | 517.55% | 91.13% | 7.91 |
| Seer, Inc. (California) (SEER) | 0.99% | $126.31M | 3.38% | 9.54% | -10.81 |
| Cognition Therapeutics, Inc. (CGTX) | 0.99% | $74.49M | N/A | N/A | N/A |
| AlloVir, Inc. (ALVR) | 0.96% | $89.73M | N/A | N/A | N/A |
| Reneo Pharmaceuticals, Inc. (RPHM) | 0.95% | $55.81M | N/A | N/A | N/A |
| iTeos Therapeutics, Inc. (ITOS) | 0.93% | $386.27M | -95.29% | 92.87% | -10.66 |
| Nautilus Biotechnology, Inc. (NAUT) | 0.93% | $317.75M | N/A | N/A | N/A |
| Graphite Bio, Inc. (GRPH) | 0.92% | $131.51M | N/A | N/A | N/A |
| LAVA Therapeutics NV (LVTX) | 0.92% | $75.98M | -65.09% | 29.68% | -6.95 |
| Jasper Therapeutics, Inc. (JSPR) | 0.89% | $360.09M | N/A | N/A | N/A |
| BioXcel Therapeutics, Inc. (BTAI) | 0.89% | $93.33M | 268.00% | -14.35% | 88.47 |
| Kezar Life Sciences, Inc. (KZR) | 0.88% | $58.50M | N/A | 84.77% | -16.24 |
| ImmuCell Corp. (ICCC) | 0.88% | $38.06M | 111.81% | N/A | N/A |
| Precigen, Inc. (PGEN) | 0.87% | $333.19M | -76.87% | -76.18% | 43.68 |
| Quince Therapeutics, Inc. (CRTX) | 0.87% | $46.24M | N/A | N/A | N/A |
| Foghorn Therapeutics, Inc. (FHTX) | 0.87% | $232.41M | 77.63% | 74.64% | 2.39 |
| Precision BioSciences, Inc. (DTIL) | 0.87% | $72.00M | 94.15% | 83.06% | -0.89 |
| BioAtla, Inc. (BCAB) | 0.87% | $108.48M | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE) | 0.87% | $92.42M | 340.88% | 37.41% | 15.84 |
| Neoleukin Therapeutics, Inc. (NLTX) | 0.86% | $442.16M | N/A | N/A | N/A |
| Avrobio, Inc. (AVRO) | 0.86% | $53.38M | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB) | 0.86% | $52.95M | -57.72% | -20.23% | 16.49 |
| Verastem, Inc. (VSTM) | 0.85% | $252.45M | N/A | N/A | N/A |
| Syros Pharmaceuticals, Inc. (SYRS) | 0.85% | $144.33M | -33.23% | 77.33% | 14.41 |
| Aspira Women's Health, Inc. (AWH) | 0.84% | $39.76M | 11.85% | 57.48% | 4.14 |
| Vor Biopharma, Inc. (VOR) | 0.84% | $117.33M | N/A | N/A | N/A |
| ImmunoPrecise Antibodies Ltd. (IPA) | 0.84% | $33.68M | 19.97% | 39.99% | 3.01 |
| Champions Oncology, Inc. (CSBR) | 0.84% | $65.93M | -5.90% | 34.70% | 1.67 |
| Cyclo Therapeutics, Inc. (CYTH) | 0.83% | $41.92M | -21.76% | -223.91% | 16.49 |
| Aadi Bioscience, Inc. (AADI) | 0.83% | $47.14M | 60.06% | 88.47% | -1.95 |
| IO Biotech, Inc. (IOBT) | 0.83% | $96.19M | N/A | N/A | N/A |
| Spruce Biosciences, Inc. (SPRB) | 0.83% | $29.13M | N/A | 99.31% | 2.09 |
| Trevi Therapeutics, Inc. (TRVI) | 0.82% | $202.05M | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO) | 0.82% | $54.07M | 29.90% | 26.49% | 1.40 |
| Instil Bio, Inc. (TIL) | 0.82% | $70.37M | N/A | N/A | N/A |
| Coeptis Therapeutics Holdings, Inc. (BHSE) | 0.82% | $11.24M | N/A | N/A | N/A |
| InflaRx NV (IFRX) | 0.82% | $80.67M | N/A | -1,548.73% | -130.92 |
| Compass Pathways Plc (CMPS) | 0.82% | $530.86M | N/A | N/A | N/A |
| Passage Bio, Inc. (PASG) | 0.81% | $79.48M | N/A | N/A | N/A |
| Enzo Biochem, Inc. (ENZ) | 0.81% | $53.27M | -47.65% | 49.39% | 0.18 |
| CARA Therapeutics, Inc. (CARA) | 0.81% | $41.10M | -49.92% | 69.32% | -0.85 |
| uniQure NV (QURE) | 0.80% | $214.06M | -85.12% | -61.13% | 14.99 |
| Ikena Oncology, Inc. (IKNA) | 0.79% | $63.70M | -41.35% | 88.86% | -9.01 |
| Voyager Therapeutics, Inc. (VYGR) | 0.79% | $424.63M | 511.16% | 98.22% | 0.66 |
| Elutia, Inc. (AZYO) | 0.79% | $55.50M | -49.69% | 44.67% | 2.47 |
| OncoCyte Corp. (OCX) | 0.79% | $20.60M | 56.89% | -56.62% | 11.77 |
| Monte Rosa Therapeutics, Inc. (GLUE) | 0.78% | $266.82M | N/A | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX) | 0.76% | $94.74M | N/A | N/A | 562.51 |
| Adaptimmune Therapeutics Plc (ADAP) | 0.76% | $304.12M | 123.04% | 83.71% | 0.62 |
| PepGen Inc. (PEPG) | 0.75% | $397.74M | N/A | N/A | N/A |
| Prelude Therapeutics, Inc. (PRLD) | 0.75% | $207.05M | N/A | N/A | N/A |
| Spero Therapeutics, Inc. (SPRO) | 0.75% | $76.53M | 99.13% | 99.62% | 0.07 |
| Larimar Therapeutics, Inc. (LRMR) | 0.75% | $439.58M | N/A | N/A | N/A |
| Xeris Biopharma Holdings, Inc. (XERS) | 0.74% | $259.44M | 48.68% | 75.91% | 2.93 |
| Vigil Neuroscience, Inc. (VIGL) | 0.73% | $98.10M | N/A | N/A | N/A |
| SAB Biotherapeutics, Inc. (SABS) | 0.73% | $39.58M | -90.63% | -67.28% | -5.67 |
| Akoya Biosciences, Inc. (AKYA) | 0.73% | $188.63M | 29.09% | 49.92% | 2.27 |
| MeiraGTx Holdings Plc (MGTX) | 0.72% | $313.82M | -11.95% | 2.05% | 25.41 |
| Heron Therapeutics, Inc. (HRTX) | 0.71% | $349.48M | 17.99% | 48.75% | 2.63 |
| Athira Pharma, Inc. (ATHA) | 0.71% | $75.50M | N/A | N/A | N/A |
| Poseida Therapeutics, Inc. (PSTX) | 0.71% | $234.57M | -50.42% | 91.32% | 2.72 |
| Replimune Group, Inc. (REPL) | 0.70% | $389.81M | N/A | N/A | N/A |
| Nascent Biotech, Inc. (NBIO) | 0.69% | $16.96M | N/A | N/A | N/A |
| Spyre Therapeutics, Inc. (AGLE) | 0.69% | $1.19B | -61.96% | -8.80% | 88.75 |
| Greenwich LifeSciences, Inc. (GLSI) | 0.67% | $159.95M | N/A | N/A | N/A |
| Compugen Ltd. (CGEN) | 0.67% | $172.79M | 346.12% | 92.59% | 3.70 |
| C4 Therapeutics, Inc. (CCCC) | 0.66% | $433.48M | -33.25% | 62.72% | 4.71 |
| Carisma Therapeutics, Inc. (SESN) | 0.66% | $67.71M | -62.70% | 44.60% | 1.59 |
| BioVie, Inc. (BIVI) | 0.66% | $26.91M | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX) | 0.64% | $47.52M | -60.62% | -45.67% | 484.14 |
| Solid Biosciences, Inc. (SLDB) | 0.64% | $334.90M | -100.00% | N/A | N/A |
| Altimmune, Inc. (ALT) | 0.63% | $464.36M | N/A | -11.97% | 943.29 |
| Sangamo Therapeutics, Inc. (SGMO) | 0.62% | $104.87M | 58.34% | 87.41% | 0.29 |
| Vaxart, Inc. (VXRT) | 0.62% | $126.39M | 6,796.26% | 39.02% | 9.45 |
| Mersana Therapeutics, Inc. (MRSN) | 0.59% | $387.89M | 38.65% | 95.88% | 2.55 |
| Immunome, Inc. (IMNM) | 0.59% | $839.30M | N/A | 94.81% | 5.41 |
| Invivyd, Inc. (ADGI) | 0.58% | $264.67M | N/A | N/A | N/A |
| Omega Therapeutics, Inc. (OMGA) | 0.58% | $123.00M | 49.25% | -118.84% | 70.32 |
| Century Therapeutics, Inc. (IPSC) | 0.55% | $188.93M | -57.01% | -483.62% | 32.37 |
| Nkarta, Inc. (NKTX) | 0.52% | $470.72M | N/A | N/A | N/A |
| Kodiak Sciences, Inc. (KOD) | 0.52% | $168.60M | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE) | 0.50% | $449.58M | -34.03% | 71.22% | 2.46 |
| Renovaro, Inc. (ENOB) | 0.47% | $227.00M | N/A | N/A | N/A |
| Ventyx Biosciences, Inc. (VTYX) | 0.46% | $263.67M | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV) | 0.38% | $31.04M | N/A | N/A | N/A |
| Gritstone bio, Inc. (GRTS) | 0.32% | $85.12M | -85.64% | -470.32% | 194.50 |
| eFFECTOR Therapeutics, Inc. (EFTR) | 0.20% | $10.58M | -100.00% | N/A | N/A |
| Vaxxinity, Inc. (VAXX) | 0.15% | $15.56M | N/A | N/A | N/A |
Market data by FactSet
